Thursday, June 13, 2024

Why Is There No Cure For Hiv

What Should I Do Until Theres A Cure For Hiv

Medications Now Available That Can Prevent AIDS, Turn Disease Into Treatable Condition

For now, the best thing to do for your health is to test regularly for HIV. Testing is the only way to know for sure if you have the virus.

If youve already tested and your result is positive, youll be advised to start antiretroviral treatment as soon as possible. Treatment is the only way to manage HIV and prevent it from damaging your immune system. It also reduces the risk of passing HIV on to your sexual partners. With treatment, people living with HIV can have long and healthy lives.

Why Do We Need A Vaccine To Prevent Hiv

Today, more people living with HIV than ever before have access to life-saving treatment with HIV medicines , which is good for their health. When people living with HIV achieve and maintain viral suppression by taking HIV medication daily as prescribed, they can stay healthy and have effectively no risk of sexually transmitting HIV to their partners. In addition, others who are at high risk for HIV infection may have access to pre-exposure prophylaxis , or ART being used to prevent HIV. Yet, unfortunately, in 2018, 37,968 people were diagnosed with HIV infection in the United States, and in 2019, approximately 1.7 million people newly acquired HIV worldwide. To control and ultimately end HIV globally, we need a powerful array of HIV prevention tools that are widely accessible to all who would benefit from them.

Vaccines historically have been the most effective means to prevent and even eradicate infectious diseases. They safely and cost-effectively prevent illness, disability, and death. Like smallpox and polio vaccines, a preventive HIV vaccine could help save millions of lives.

Developing safe, effective, and affordable vaccines that can prevent HIV infection in uninfected people is the NIHs highest HIV research priority given its game-changing potential for controlling and ultimately ending the HIV/AIDS pandemic.


We Should Applaud These Groundbreaking Discoveries But Were Not At The Finish Line Yet

This is why the Global Fund, the organization that receives 100% of money generated by partners, is so important. While the medical community continues to work on finding a safe, cost-effective cure for HIV/AIDS, Global Fund programs in over 100 countries are focused on scaling up access to daily antiretroviral medicationthe current, closest thing to a cure for people living with HIV. These programs also provide prevention services, care, treatment and education to the people most affected by HIV, which are crucial to limiting the spread of the virus.

Given the devastating impact of the current COVID-19 pandemic on the fight to end AIDS, supporting the Global Fund is more crucial now than ever before. Join and help ensure those living with HIV can continue to access essential programs and services.

Read Also: How Does The Immune System Fight Hiv

Current Status Of Hiv Vaccine Development

The first priority in light of the positive results from the RV144 trial is for researchers to determine the correlate of protection from the prime-boost vaccine combination: that is, they must determine precisely;how;the prime-boost combination protected against infection with HIV. Researchers have studied the antibodies induced by the prime-boost combination ; whether T-cell responses occurred; and whether the individual genetics of the studys participants played a role in their responses to the vaccine combination. A study published in 2012 indicates that T-cell responses likely did not play a role in protecting against infection, and that the vaccines efficacy was related to antibody responses to certain regions of viral envelope proteins.

Additional studies are ongoing to try to understand and improve upon the immune response generated in the RV144 trial. The;P5 Partnership; has planned sequential future efficacy studies of RV144.

Efforts and approaches completely separate from the RV144 trial are underway. Researchers are studying the previously mentioned elite controllers whose HIV infections never progress to AIDS, in hopes that whatever innate ability they have to control HIV might provide insights for vaccine development. Efforts are also being made to study individuals who never become infected with HIV despite being exposed to it repeatedly.

Fifty Years Of Hiv: How Close Are We To A Cure

Preventive treatment for people at high risk of HIV ...

Its half a century since the first known HIV-related death and two patients appear to have been cured of the virus. What does this mean for the 37 million still living with it?

Nobody knew what killed Robert Rayford. The African American boy was just 15 years old when he presented at St Louis city hospital in late 1968, but the medical team drew a blank.

Unexplained swelling in Rayfords genitalia soon spread throughout his body. Chlamydia bacteria, usually localised at the point of entry, coursed through his bloodstream. A small purple lesion on the inside of his thigh signalled cancer, but of a form usually found in elderly Ashkenazi Jews and Italians, not teenage black boys who had never left Missouri.

The teenager hardly spoke during the 18 months in which he received treatment at three separate hospitals. He was the typical 15-year-old who is not going to talk to adults, especially when Im white and hes black, one of his doctors would tell the St Louis Post-Dispatch almost two decades later. He told them he had sex with a girl from his neighbourhood, but gave little else away.

Tragically, pneumonia ended Rayfords young life during the night of 15 May 1969, but his body had been compromised some time before. Illnesses that a healthy body would ordinarily expunge met with no resistance. Rayfords clinicians, puzzled by his decline, persuaded his family to submit his body to an autopsy and preserved samples for inspection at a later date.

You May Like: How Is Hiv Transmitted Through Blood

Off Treatment And Still Undetectable

One approach to curing HIV is called treatment-free remission, or ART-free remission. This approach is also called a functional cure, because it would render HIV harmless without eliminating HIV from the body completely.

ART does a great job at eliminating HIV from the circulating blood of a PLWH, which is what keeps those on ART healthy and makes it impossible for those who are virally suppressed for at least six months to transmit HIV to their sexual partners . But even with viral suppression by ART, HIV remains hidden in a so-called HIV reservoir made up of immune system cells that contain HIV in the form of HIV DNA . Such HIV is called latent, because it hides from detection by the immune systemand these cells are called resting, because they are not actively producing new copies of the virus.

When latently infected, resting immune cells are reactivated, they begin to churn out new copies of fully active HIV. This explains why PLWH need to remain on ART throughout their entire lifeif ART stops, detectable virus comes back.

Finding ways to prevent the latent reservoir from becoming productive after stopping ART is thus a major focus of research into a cure for HIV today. This kind of sustained ART-free remission, sometimes called a functional cure, would allow a PLWH to keep latent virus suppressed without daily medication. Researchers are investigating a number of different strategies for achieving ART-free remission of HIV.

The Complexity Of Hiv

What is the problem? The biological properties that HIV has evolved make development of a successful vaccine very, very difficult. What are those properties?

First and foremost is the continuous unrelenting virus replication. Once HIV gets its foot in the door, its gotcha. Many vaccines do not protect absolutely against the acquisition of an infection, but they are able to severely limit the replication of the virus and any illness that might result. For a vaccine to be effective against HIV, it will likely need to provide an absolute sterilizing barrier and not just limit viral replication.

HIV has evolved an ability to generate and to tolerate many mutations in its genetic information. The consequence of this is an enormous amount of variation among strains of the virus not only from one individual to another but even within a single individual. Lets use influenza for a comparison. Everyone knows that people need to get revaccinated against influenza virus each season because of season-to-season variability in the influenza strain that is circulating. Well, the variability of HIV within a single infected individual exceeds the entire worldwide sequence variability in the influenza virus during an entire season.

What are we going to put into a vaccine to cover this extent of strain variability?

We are making progress. We must not give up.

Don’t Miss: How To Test For Hiv At Home

Researching An Hiv Cure: The Main Approaches

  • ‘Activate and eradicate’ aims to flush the virus out of its reservoirs and then kill any cells it infects.
  • Gene editing changing immune cells so they cant be infected by HIV.
  • Immune modulation permanently changing the immune system to better fight HIV.
  • Stem cell transplants replacing a persons infected immune system with a donor immune system.
  • Although the stem cell approach has had some success in the past, its very dangerous for the patient. It would only be considered a viable option, if the person needed a stem cell transplant to treat another more deadly condition, such as very advanced leukaemia which, unlike HIV, doesnt have as many other safe and effective treatment options available.

    While there is promising research being carried out in these areas, there is no viable cure on the horizon.

    Testing Hiv Vaccine Candidates

    Why its so hard to cure HIV/AIDS – Janet Iwasa

    To date, there have been only a handful of clinical trials to test the efficacy of potential HIV vaccines in people. Of the six trials that scientists saw to completion, only one vaccine candidate proved effective at preventing infection.

    That lone successful trial, known as RV144, used a prime-boost strategy in which participants received a total of six shots. The four prime jabs contained a canarypox virus that is incapable of replicating in cells and carries the genetic instructions for select HIV proteins. The participants cells make those viral proteins and develop an immune response against them.

    Then participants also received two boosts, an injection of an HIV protein fragment that is essential for the virus to enter cells. The hope was that participants would develop a strong, wide-ranging immune response, giving those people broad protection against a variety of HIV subtypes.

    Ultimately, that vaccine strategy lowered the risk of infection by 31.2 percent in vaccinated participants compared with the unvaccinated group. Although the shot showed only modest efficacy, those results changed the field by homing in on what type of immune response people needed to prevent infection, Zolla-Pazner says.

    Recommended Reading: Can Hiv Be Transferred By Saliva

    Induce And Reduce: Our Approach To Hiv Cure

    HIV is a sneaky virus that can persist in a small population of cells even while its spread to new cells is being suppressed by ARVs. Unless we can find a way to expose hidden HIV and selectively target these cells, well continue to require chronic treatments to keep the virus at bay. Thats why cure research currently underway by Qura Therapeutics and ViiV Healthcare targets these pockets of virus through the concept of induce and reduce.

    This strategy is first focused on driving HIV hidden in human immune cells to make viral proteins that allow the cells with HIV to be recognised . Once cells harbouring HIV are exposed, drugs can then tag these reservoir cells for elimination by the host immune system . The Induce and Reduce agents will all be given while people are on suppressive ARV therapy to protect healthy cells from the virus. While it may sound straight forward, it has been a major challenge to reactivate the virus in animals or people in an effective and safe way.

    The research required to develop an HIV cure is complex and requires a commitment to the long-term. As we look ahead to the future, were optimistic that the initial steps weve taken towards establishing our approach to HIV cure will move from the laboratory into clinical studies in people, big steps in the long journey to finding a cure for HIV. It is our lifes work to end the HIV epidemic, and we will be here until HIV isnt.


    So Where Are We Now And Is It Worth It

    If an effective HIV vaccine is that hard to create, will we ever get there? Thats a really tough question, said Jefferys. In science, there can always be surprises, good and bad. Its possible that Janssens will have protective power.

    Hes referring to a vaccine from Janssen, a Johnson & Johnson subsidiary, that has recently been in a phase 3 trial among cisgender men who have sex with men and transgender people in Latin America, Europe, and the U.S., alongside a phase 2b trial among cisgender women at high risk for HIV in several African countriesand that was due to be analyzing results in July. Its not an mRNA vaccine, but a so-called vector vaccine, which uses a modified version of a different virus to deliver important info to human cells on fighting off HIV. The vaccine isnt able to induce broadly neutralizing antibody responses, but rather creates other kinds of immune responses that researchers think may have a chance of preventing HIV infection.

    If the Janssen results are negative, Feinberg cautioned, that may be the last attempt to create a vaccine that sparks these types of immune responses. Future trials, he said, would only have the B-cell wing of the immune system left to concentrate on. But, cautioned Feinberg, “broadly neutralizing antibodies have to go through multiple steps of evolution to get to the structure that can bind to HIV,” meaning that creating such a vaccine will itself be a slow, multi-step process.

    Tim Murphy

    Also Check: What Does The Hiv Virus Look Like

    Why Is There No Cure For Aids

    There is no cure for AIDS. This is because caused by HIV, which is a retrovirus. It is a type of virus integrates its genetic information into a host cells own DNA. The affected DNA is then used by the host cell as if it were its own genes. This, in turn, instructs the cell to produce viral RNA. The process is cumulative and hence the whole body gets affected.

    Since the retrovirus has an ability to hide its instructions inside the cells where drugs;cannot target, the virus cant be killed and hence leaving no cure for AIDS.

    Will There Ever Be A Cure For Hiv

    HIV Vaccine

    Researchers and scientists believe we can find a cure for HIV. We know a lot about HIV, as much as certain cancers. Scientists are researching two types of cure: a functional cure and a sterilising cure.

    There is no ‘natural cure’ or ‘herbal cure’ for HIV. Antiretroviral treatment is the only medication that is proven to effectively control HIV.

    Don’t Miss: Can Hiv Positive Become Negative

    Diagnosis And Treatment Of Aids

    Presence of HIV in the body can be detected through various blood tests. Antibody/antigen tests help detect the virus within 18 45 to days of the transmission and Antibody tests can detect the same within 23 90. The most advanced test used is Nucleic acid test . It is capable of detecting the virus in the earliest stages, that is, within 5 to 21 days of the transmission.Unfortunately, there is no cure for AIDS. However, if detected early, the progress of HIV infection can be slowed down through antiretroviral therapy.

    Mapping The Path Forward To A Cure For Hiv

    How do you find a cure for HIV? Our approach is simple: collaboration. We realised a long time ago that we could go much further in our efforts if we worked to bring together the best brains in the business to focus on exploring every avenue, mechanism and compound towards our end goal of an HIV cure.

    For that reason, ViiV Healthcare became half of a unique public-private research partnership that began in 2015 with the University of North Carolina at Chapel Hill , creating a dedicated HIV Cure center and a jointly owned new biotechnology company, Qura Therapeutics, that focus exclusively on discovering a cure for HIV.

    This collaboration, the first-of-its-kind in the field of HIV cure, has unified the strengths of a world-renowned public research institution and a pioneering private industry leader. Together, ViiV Healthcare and UNC scientists became part of a joint team based in labs on the UNC Chapel Hill campus, creating and working together on several exciting areas of research to cure HIV.

    Also Check: What Are The Signs That You Are Hiv Positive

    Is There A Cure For Hiv And Aids


    • There is no cure for HIV, although antiretroviral treatment can control the virus, meaning that people with HIV can live long and healthy lives.

    • Most research is looking for a functional cure where HIV is permanently reduced to undetectable and harmless levels in the body, but some residual virus may remain.

    • Other research is looking for a sterilising cure where HIV is removed from the body completely, but this is more complicated and risky.

    • Trials of HIV vaccines are encouraging, but so far only offer partial protection.

    There is no cure for HIV yet. However, antiretroviral treatment can control HIV and allow people to live a long and healthy life.

    For some people, treatment can reduce the level of HIV in their body to such a low amount that they are unable to pass it on . Having an undetectable viral load can keep you healthy, but its not a cure for HIV. To maintain an undetectable viral load a person must keep adhering to their antiretroviral treatment.

    Second Patient Appears Cured Of Hiv Giving Hope To Hiv Positive People

    Developing a cure for HIV

    Timothy Ray Brown, the first person to be cured of H.I.V., and Dr. Ravindra Gupta, a virologist, speak on the second patient who appears to have been cured of an H.I.V. infection. That patient has chosen to remain anonymous.

    Yes, I would like to meet the London patient very much. I would say, take your time in If you want to become public, do it. And its been very useful for science and for giving hope to H.I.V. positive people. We waited 16 months before stopping in the post-transplant period just to make sure that the cancer was in remission, the patient was well and that the measures we had of the H.I.V. reservoir in the body showed that there was very, very little virus there if any at all. And at that point, we stopped the treatment. And so were now 18 months in and were confident that this will be a long-term remission, but its too early to say as to whether this is a cure or not.

    Most experts who know the details agree that the new case seems like a legitimate cure, but some are uncertain of its relevance for AIDS treatment overall.

    Im not sure what this tells us, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. It was done with Timothy Ray Brown, and now heres another case ok, so now what? Now where do we go with it?

    These are dreams, right? Things on the drawing table, Dr. McCune said. These dreams are motivated by cases like this it helps us to imagine what might be done in the future.

    Don’t Miss: Are Hiv And Aids The Same

    Popular Articles
    Related news